-Translation-
IP_OCS/008/2022
June 10, 2022
Subject: Postponement of the Extraordinary General Meeting of Shareholders No. 1/2022
To: President
The Stock Exchange of Thailand
According to the Board of Directors' Meeting of Inter Pharma Public Company Limited (the "Company") No. 4/2022, which was held on May 19, 2022, resolved to determine the date for the Extraordinary General Meeting of Shareholders No. 1/2022 on July 22, 2022, at 2.00 p.m. In this regard, the meeting will be held on an electronic platform, as previously informed.
The Chief Executive Officer, who has been authorized by the Board of Director Meeting No. 4/2022, which was held on May 19, 2022, to have the power to consider and approve the amendment and/or add additional content as well as the agenda of the Extraordinary General Meeting of Shareholders No. 1/2022, including the amendment or change the date, time and venue for the Extraordinary General Meeting of Shareholders No. 1/2022 if the Company faces problems in preparing documents and information, in which such document and information for submission to the Shareholders shall be done within the period specified by the related laws and regulations. In this connection, if an event causes it to be necessary to amend or change the said date and time, the Chief Executive Officer shall have the power to consider upon the discretion.
Due to some directors are on urgent duties and this meeting is to consider and approve the capital increase agenda which is significant to the Company. The Chief Executive Officer, therefore, agreed to postpone the Extraordinary General Meeting of Shareholders No. 1/2022 so that the Board of Directors of the Company could attend and participate in the meeting by changing the date of the Extraordinary General Meeting of Shareholders No. 1/2022 from July 22, 2022 at
2.00 p.m. to July 20, 2022 at 2.00 p.m., which the meeting still be in an electronic platform. The Record Date will be on June 20, 2022, and the meeting agenda shall remain the same.
Please be informed accordingly.
Yours sincerely,
-Signature-
Dr. Trinnawat Thanitnithiphan
Chief Executive Officer
บริษัท อินเตอร์ ฟาร์มา จ(มหาชน)ากัด เลขที่140/9 อาคารไอทีเอฟ ชั้น 9 ถนนสีลม แขวงสุริยวงศ์ เขตบางรัก กรุงเทพมหานคร10500 โทรศัพท์ 02-634-0225 แฟ็ กซ์ 02-634-0135www.interpharma.co.thInter Pharma Public Company Limited 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawongse, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135www.interpharma.co.th